- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x YB: YTTERBIUM (III) ION(Non-functional Binders)
- 4 x 3XG: ethyl ({4-oxo-3-[3-(pyrrolidin-1-yl)propyl]-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetate(Non-covalent)
3XG.3: 15 residues within 4Å:- Chain A: S.121, G.125, T.129, F.171, V.174, M.175, W.178, Y.297, C.302, C.303, I.304, Y.457, G.458, V.460, F.466
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.174, A:V.460
- pi-Stacking: A:F.171, A:W.178, A:F.466
3XG.12: 15 residues within 4Å:- Chain B: S.121, G.125, T.129, F.171, V.174, M.175, W.178, Y.297, C.302, C.303, I.304, Y.457, G.458, V.460, F.466
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:V.174, B:V.460
- pi-Stacking: B:F.171, B:W.178, B:F.466
3XG.21: 15 residues within 4Å:- Chain C: S.121, G.125, T.129, F.171, V.174, M.175, W.178, Y.297, C.302, C.303, I.304, Y.457, G.458, V.460, F.466
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:V.174, C:V.460
- pi-Stacking: C:F.171, C:W.178, C:F.466
3XG.30: 15 residues within 4Å:- Chain D: S.121, G.125, T.129, F.171, V.174, M.175, W.178, Y.297, C.302, C.303, I.304, Y.457, G.458, V.460, F.466
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:V.174, D:V.460
- pi-Stacking: D:F.171, D:W.178, D:F.466
- 16 x CL: CHLORIDE ION(Non-functional Binders)
CL.4: 3 residues within 4Å:- Chain A: R.143, T.155, H.157
Ligand excluded by PLIPCL.5: 5 residues within 4Å:- Chain A: E.349
- Ligands: YB.2, CL.6, CL.7, NAI.8
Ligand excluded by PLIPCL.6: 3 residues within 4Å:- Ligands: YB.2, CL.5, CL.7
Ligand excluded by PLIPCL.7: 5 residues within 4Å:- Chain A: E.349
- Ligands: YB.2, CL.5, CL.6, NAI.8
Ligand excluded by PLIPCL.13: 3 residues within 4Å:- Chain B: R.143, T.155, H.157
Ligand excluded by PLIPCL.14: 5 residues within 4Å:- Chain B: E.349
- Ligands: YB.11, CL.15, CL.16, NAI.17
Ligand excluded by PLIPCL.15: 3 residues within 4Å:- Ligands: YB.11, CL.14, CL.16
Ligand excluded by PLIPCL.16: 5 residues within 4Å:- Chain B: E.349
- Ligands: YB.11, CL.14, CL.15, NAI.17
Ligand excluded by PLIPCL.22: 3 residues within 4Å:- Chain C: R.143, T.155, H.157
Ligand excluded by PLIPCL.23: 5 residues within 4Å:- Chain C: E.349
- Ligands: YB.20, CL.24, CL.25, NAI.26
Ligand excluded by PLIPCL.24: 3 residues within 4Å:- Ligands: YB.20, CL.23, CL.25
Ligand excluded by PLIPCL.25: 5 residues within 4Å:- Chain C: E.349
- Ligands: YB.20, CL.23, CL.24, NAI.26
Ligand excluded by PLIPCL.31: 3 residues within 4Å:- Chain D: R.143, T.155, H.157
Ligand excluded by PLIPCL.32: 5 residues within 4Å:- Chain D: E.349
- Ligands: YB.29, CL.33, CL.34, NAI.35
Ligand excluded by PLIPCL.33: 3 residues within 4Å:- Ligands: YB.29, CL.32, CL.34
Ligand excluded by PLIPCL.34: 5 residues within 4Å:- Chain D: E.349
- Ligands: YB.29, CL.32, CL.33, NAI.35
Ligand excluded by PLIP- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
NAI.8: 31 residues within 4Å:- Chain A: I.166, I.167, P.168, W.169, N.170, K.193, A.195, E.196, Q.197, Y.225, G.226, P.227, G.230, A.231, F.244, T.245, G.246, S.247, V.250, E.269, L.270, G.271, C.303, E.349, Q.350, K.353, E.400, F.402
- Ligands: YB.2, CL.5, CL.7
16 PLIP interactions:16 interactions with chain A- Hydrophobic interactions: A:P.168
- Hydrogen bonds: A:I.167, A:N.170, A:K.193, A:E.196, A:Q.197, A:G.246, A:S.247, A:S.247, A:E.269, A:C.303, A:Q.350, A:K.353, A:K.353
- Water bridges: A:T.248
- pi-Stacking: A:F.402
NAI.17: 31 residues within 4Å:- Chain B: I.166, I.167, P.168, W.169, N.170, K.193, A.195, E.196, Q.197, Y.225, G.226, P.227, G.230, A.231, F.244, T.245, G.246, S.247, V.250, E.269, L.270, G.271, C.303, E.349, Q.350, K.353, E.400, F.402
- Ligands: YB.11, CL.14, CL.16
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:P.168
- Hydrogen bonds: B:I.167, B:N.170, B:K.193, B:E.196, B:Q.197, B:G.246, B:S.247, B:S.247, B:E.269, B:C.303, B:Q.350, B:K.353, B:K.353
- Water bridges: B:T.248
- pi-Stacking: B:F.402
NAI.26: 31 residues within 4Å:- Chain C: I.166, I.167, P.168, W.169, N.170, K.193, A.195, E.196, Q.197, Y.225, G.226, P.227, G.230, A.231, F.244, T.245, G.246, S.247, V.250, E.269, L.270, G.271, C.303, E.349, Q.350, K.353, E.400, F.402
- Ligands: YB.20, CL.23, CL.25
17 PLIP interactions:17 interactions with chain C- Hydrophobic interactions: C:P.168
- Hydrogen bonds: C:I.167, C:N.170, C:K.193, C:E.196, C:Q.197, C:G.246, C:S.247, C:S.247, C:E.269, C:C.303, C:Q.350, C:K.353, C:K.353, C:E.400
- Water bridges: C:T.248
- pi-Stacking: C:F.402
NAI.35: 31 residues within 4Å:- Chain D: I.166, I.167, P.168, W.169, N.170, K.193, A.195, E.196, Q.197, Y.225, G.226, P.227, G.230, A.231, F.244, T.245, G.246, S.247, V.250, E.269, L.270, G.271, C.303, E.349, Q.350, K.353, E.400, F.402
- Ligands: YB.29, CL.32, CL.34
17 PLIP interactions:17 interactions with chain D- Hydrophobic interactions: D:P.168
- Hydrogen bonds: D:I.167, D:N.170, D:K.193, D:E.196, D:Q.197, D:G.246, D:S.247, D:S.247, D:E.269, D:C.303, D:Q.350, D:K.353, D:K.353, D:E.400
- Water bridges: D:T.248
- pi-Stacking: D:F.402
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.9: 5 residues within 4Å:- Chain A: H.484, E.485
- Chain B: H.484, E.485
- Ligands: NA.18
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.485
NA.18: 5 residues within 4Å:- Chain A: H.484, E.485
- Chain B: H.484, E.485
- Ligands: NA.9
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.485
NA.27: 5 residues within 4Å:- Chain C: H.484, E.485
- Chain D: H.484, E.485
- Ligands: NA.36
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.485
NA.36: 5 residues within 4Å:- Chain C: H.484, E.485
- Chain D: H.484, E.485
- Ligands: NA.27
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.485
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morgan, C.A. et al., Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors. J.Med.Chem. (2015)
- Release Date
- 2015-02-11
- Peptides
- Retinal dehydrogenase 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x YB: YTTERBIUM (III) ION(Non-functional Binders)
- 4 x 3XG: ethyl ({4-oxo-3-[3-(pyrrolidin-1-yl)propyl]-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetate(Non-covalent)
- 16 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morgan, C.A. et al., Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors. J.Med.Chem. (2015)
- Release Date
- 2015-02-11
- Peptides
- Retinal dehydrogenase 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A